⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

BALAXI PHARMACEUTICALS LIMITEDBALAXI

BALAXI PHARMACEUTICALS LIMITED (BALAXI) is an NSE-listed company. This page brings together its recent bulk & block deals, AI-scored exchange filings and corporate actions.

Net institutional flow

14.8 Cr

Institutional buyers

7 in / 6 out

High-impact filings

0 · tilt Neutral

Next corporate action

Competitive landscape — the read

vs most-traded names · 6M
Institutional money is backing ATALREAL hardest (+7.2 Cr net). BALAXI ranks #2 of 7 on flow (net buying +1.8 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+7.2 Cr157
2BALAXIThis+1.8 Cr3
3QUADFUTURE+0.1 Cr148
4MOBIKWIK+0.1 Cr83
5MTNL+0 Cr2
6GATECH+0 Cr8
7IRMENERGY2.2 Cr328

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — BALAXI day by day

  1. 2026-06-16FilingBALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper PublicationCompliance
  2. 2026-03-24BulkBUY · ₹0.9 CrRGSL INVESTMENT LVF 1
  3. 2026-03-24NetDay net +₹0.9 Cr
  4. 2026-03-23BulkBUY · ₹0.9 CrRGSL INVESTMENT LVF 1
  5. 2026-03-23NetDay net +₹0.9 Cr
  6. 2025-12-31BulkBUY · ₹1.2 CrMITHUN KHAITAN
  7. 2025-12-31NetDay net +₹1.2 Cr

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

Bulk & block deals

3 deals · 2025-12-31 → 2026-03-24

DateCounterpartyTypeSideValue
2026-03-24RGSL INVESTMENT LVF 1InstitutionBUY₹0.9 Cr
2026-03-23RGSL INVESTMENT LVF 1InstitutionBUY₹0.9 Cr
2025-12-31MITHUN KHAITANHNI / otherBUY₹1.2 Cr

3 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on BALAXI

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.